Leadership team
Dr. Richard Mollard Managing Director
Dr. Richard Mollard Managing Director
Dr. Richard Mollard Managing Director
Richard has extensive national and international experience in cancer drug development, clinical strategy, technical diligence, IP capture and international regulatory affairs. Over the past 25 years he has worked with large pharma such as Bristol Myers Squibb and Eli Lilly & Company and as CEO and CSO for listed, startup and private biotech companies.
Mark Lawrence Director
Dr. Richard Mollard Managing Director
Dr. Richard Mollard Managing Director
Mark has been a leader in the Urology industry for over 35 years. He has introduced 8 new products into the market that became standard of care. He has been a Director of another Pharma start-up for 4 years that is commencing FDA trials. He is a change agent.
Dr. Donald Murphy Science Director
Dr. Richard Mollard Managing Director
Dr. Donald Murphy Science Director
Emeritus Consultant Surgeon. Multi-International awarded, research orientated projects. Doctorate in Medicine 2012 and RACS Medalist in 2019.
Commenced the unique scientific investigations of Photodynamic Therapy. Continuing with PDT research, including Immunotherapy in association with the Monash Hudson Institute. The aim is to introduce Immuno-Photodynamic Therapy, to mainstream Prostate Cancer management.
Hon Cho Operations Director
Dr. Richard Mollard Managing Director
Dr. Donald Murphy Science Director
Hon has extensive operational and financial expertise in diverse corporate segments, combined with his tenure at listed and private companies, brings invaluable financial acumen and experience.